C1 esterase inhibitor (C1-INH) can reduce plasma concentrations of the complement activation product C5a.
W
W
Nürnberger
K
K
Petrik
S
S
Burdach
U
U
Göbel
D002199:Capillary Permeability / Q000187:drug effects*; D003174:Complement C1 Inactivator Proteins / Q000627:therapeutic use*; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D011292:Premedication; D012772:Shock, Septic / Q000628:therapy*
D003174:Complement C1 Inactivator Proteins; D007376:Interleukin-2